Cargando…
Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
The purpose of this paper was to systematically review the literature related to research about the factors affecting treatment adherence and discontinuation of atomoxetine in pediatric, adolescent, and adult patients with attention-deficit/hyperactivity disorder (ADHD). Medline was systematically s...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862343/ https://www.ncbi.nlm.nih.gov/pubmed/27217754 http://dx.doi.org/10.2147/NDT.S97724 |
_version_ | 1782431355070578688 |
---|---|
author | Treuer, Tamás Méndez, Luis Montgomery, William Wu, Shenghu |
author_facet | Treuer, Tamás Méndez, Luis Montgomery, William Wu, Shenghu |
author_sort | Treuer, Tamás |
collection | PubMed |
description | The purpose of this paper was to systematically review the literature related to research about the factors affecting treatment adherence and discontinuation of atomoxetine in pediatric, adolescent, and adult patients with attention-deficit/hyperactivity disorder (ADHD). Medline was systematically searched using the following prespecified terms: “ADHD”, “Adherence”, “Compliance”, “Discontinuation”, and “Atomoxetine”. We identified 31 articles that met all inclusion and exclusion criteria. The findings from this review indicate that persistence and adherence to atomoxetine treatment were generally high. Factors found to influence adherence and nonadherence to atomoxetine treatment in ADHD in this review include age, sex, the definition of response used, length of treatment, initial dose of treatment, comorbid conditions, and reimbursement. Tolerability was cited as an important reason for treatment discontinuation. More research is needed to understand those factors that can help to identify patients at risk for poor adherence and interventions that could improve treatment adherence early in the stage of this illness to secure a better long-term prognosis. |
format | Online Article Text |
id | pubmed-4862343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48623432016-05-23 Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review Treuer, Tamás Méndez, Luis Montgomery, William Wu, Shenghu Neuropsychiatr Dis Treat Review The purpose of this paper was to systematically review the literature related to research about the factors affecting treatment adherence and discontinuation of atomoxetine in pediatric, adolescent, and adult patients with attention-deficit/hyperactivity disorder (ADHD). Medline was systematically searched using the following prespecified terms: “ADHD”, “Adherence”, “Compliance”, “Discontinuation”, and “Atomoxetine”. We identified 31 articles that met all inclusion and exclusion criteria. The findings from this review indicate that persistence and adherence to atomoxetine treatment were generally high. Factors found to influence adherence and nonadherence to atomoxetine treatment in ADHD in this review include age, sex, the definition of response used, length of treatment, initial dose of treatment, comorbid conditions, and reimbursement. Tolerability was cited as an important reason for treatment discontinuation. More research is needed to understand those factors that can help to identify patients at risk for poor adherence and interventions that could improve treatment adherence early in the stage of this illness to secure a better long-term prognosis. Dove Medical Press 2016-05-03 /pmc/articles/PMC4862343/ /pubmed/27217754 http://dx.doi.org/10.2147/NDT.S97724 Text en © 2016 Treuer et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Treuer, Tamás Méndez, Luis Montgomery, William Wu, Shenghu Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review |
title | Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review |
title_full | Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review |
title_fullStr | Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review |
title_full_unstemmed | Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review |
title_short | Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review |
title_sort | factors affecting treatment adherence to atomoxetine in adhd: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862343/ https://www.ncbi.nlm.nih.gov/pubmed/27217754 http://dx.doi.org/10.2147/NDT.S97724 |
work_keys_str_mv | AT treuertamas factorsaffectingtreatmentadherencetoatomoxetineinadhdasystematicreview AT mendezluis factorsaffectingtreatmentadherencetoatomoxetineinadhdasystematicreview AT montgomerywilliam factorsaffectingtreatmentadherencetoatomoxetineinadhdasystematicreview AT wushenghu factorsaffectingtreatmentadherencetoatomoxetineinadhdasystematicreview |